ScoliCare

The vendor opportunity at ScoliCare

ScoliCare operates in the health services segment with 4 franchised units and no disclosed company-owned locations. The system’s average unit volume (AUV) is $889,959, and the royalty rate is 5% of gross revenue. Initial franchise terms run 5 years, with renewal terms also set at 5 years. Year-over-year unit growth stands at 33.3%, signaling an expanding footprint despite the small base. For software vendors, the immediate addressable market is limited to these 4 units, but the growth trajectory and mandated tech stack create a clear entry point for tools that integrate with or complement existing systems.

Who controls software purchasing

Software purchasing decisions at ScoliCare are centralized at headquarters. The FDD’s Item 1 lists four executives: Jeb McAviney (Chief Executive Officer and Chairman of the Board of Directors), Michelle McAviney (Chief Innovation Officer), Melanie Ward (Chief Operating Officer), and Andrew Lyme (Chief Commercial Officer). The Chief Innovation Officer and Chief Operating Officer are the most likely buyers for operational and clinical software, while the Chief Commercial Officer may influence sales and marketing technology choices. No multi-unit operators are mapped in our corpus, reinforcing that all purchasing authority rests with the franchisor.

Mandated and current tech stack

ScoliCare mandates three core systems across its franchise network. Cliniko serves as the practice management platform, Salesforce by Salesforce, Inc. handles customer relationship management, and Xero by Xero Limited is the required accounting software. These mandates are explicit in the FDD, meaning any software vendor pitching ScoliCare must address integration with or displacement of these tools. The absence of a mandated POS or other operational systems may reflect the clinical, non-retail nature of the business. Vendors offering complementary solutions in telehealth, patient engagement, or compliance should position against this existing stack.

Procurement, renewals, and timing

The FDD does not include an Item 8 extract detailing procurement restrictions, so it is unclear whether ScoliCare uses a designated supplier model, an approved supplier list, or an open procurement process. This gap means vendors should inquire directly about supplier qualification requirements during initial conversations. On renewal timing, Item 17 outlines conditions including notice, satisfaction of monetary obligations, compliance with the Franchise Agreement, execution of a release, and signing a new Franchise Agreement. With 5-year initial and renewal terms and recent unit growth, software evaluation windows may coincide with new franchise onboarding or renewal negotiations.

How to read the ScoliCare FDD

The 2025 ScoliCare Franchise Disclosure Document is filed with state franchise regulators and available for review in the embedded viewer below. Key sections for software vendors include Item 1 (executive team), Item 11 (mandated systems), and Item 17 (renewal and contract timing). The FDD confirms a lean, centrally controlled operation with a small but growing unit count. For a ranked target list of franchise systems aligned with your software category, FranCloud can help you prioritize opportunities like ScoliCare.